0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Misoprostol Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-24D7622
Home | Market Reports | Health | Reproductive Health
Global Misoprostol Market Insights and Forecast to 2028

Global Misoprostol Market Insights and Forecast to 2028

Code: QYRE-Auto-24D7622
Report
May 2022
111 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Misoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions.
Market Analysis and Insights: Global Misoprostol Market

Due to the COVID-19 pandemic, the global Misoprostol market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, 200 ug Tablets accounting for % of the Misoprostol global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Gastric Ulcer segment is altered to an % CAGR throughout this forecast period.
China Misoprostol market size is valued at US$ million in 2021, while the US and Europe Misoprostol are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Misoprostol landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Misoprostol include Cardinal Health, PD-Rx Pharmaceutical, Pfizer, Aidarex Pharmaceuticals, Cadila Healthcare, Monsanto/Searle, Shanghai Xinhualian Pharmaceutical, China Resources Zizhu Pharmaceutical and Zhejiang Xianju Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Misoprostol Scope and Segment
Misoprostol market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Misoprostol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

200 ug Tablets
100 ug Tablets

Segment by Application

Gastric Ulcer
Duodenal Ulcer
Peptic Ulcer
Anti-Early Pregnancy
Other

BY COMPANY

Cardinal Health
PD-Rx Pharmaceutical
Pfizer
Aidarex Pharmaceuticals
Cadila Healthcare
Monsanto/Searle
Shanghai Xinhualian Pharmaceutical
China Resources Zizhu Pharmaceutical
Zhejiang Xianju Pharmaceutical
Hubei Gedian Renfu Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Misoprostol Product Introduction
1.2 Market by Type
1.2.1 Global Misoprostol Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 200 ug Tablets
1.2.3 100 ug Tablets
1.3 Market by Application
1.3.1 Global Misoprostol Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Gastric Ulcer
1.3.3 Duodenal Ulcer
1.3.4 Peptic Ulcer
1.3.5 Anti-Early Pregnancy
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Misoprostol Sales Estimates and Forecasts 2017-2028
2.2 Global Misoprostol Revenue Estimates and Forecasts 2017-2028
2.3 Global Misoprostol Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Misoprostol Sales by Region
2.4.1 Global Misoprostol Sales by Region (2017-2022)
2.4.2 Global Sales Misoprostol by Region (2023-2028)
2.5 Global Misoprostol Revenue by Region
2.5.1 Global Misoprostol Revenue by Region (2017-2022)
2.5.2 Global Misoprostol Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Misoprostol Sales by Manufacturers
3.1.1 Global Top Misoprostol Manufacturers by Sales (2017-2022)
3.1.2 Global Misoprostol Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Misoprostol in 2021
3.2 Global Misoprostol Revenue by Manufacturers
3.2.1 Global Misoprostol Revenue by Manufacturers (2017-2022)
3.2.2 Global Misoprostol Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Misoprostol Revenue in 2021
3.3 Global Misoprostol Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Misoprostol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Misoprostol Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Misoprostol Sales by Type
4.1.1 Global Misoprostol Historical Sales by Type (2017-2022)
4.1.2 Global Misoprostol Forecasted Sales by Type (2023-2028)
4.1.3 Global Misoprostol Sales Market Share by Type (2017-2028)
4.2 Global Misoprostol Revenue by Type
4.2.1 Global Misoprostol Historical Revenue by Type (2017-2022)
4.2.2 Global Misoprostol Forecasted Revenue by Type (2023-2028)
4.2.3 Global Misoprostol Revenue Market Share by Type (2017-2028)
4.3 Global Misoprostol Price by Type
4.3.1 Global Misoprostol Price by Type (2017-2022)
4.3.2 Global Misoprostol Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Misoprostol Sales by Application
5.1.1 Global Misoprostol Historical Sales by Application (2017-2022)
5.1.2 Global Misoprostol Forecasted Sales by Application (2023-2028)
5.1.3 Global Misoprostol Sales Market Share by Application (2017-2028)
5.2 Global Misoprostol Revenue by Application
5.2.1 Global Misoprostol Historical Revenue by Application (2017-2022)
5.2.2 Global Misoprostol Forecasted Revenue by Application (2023-2028)
5.2.3 Global Misoprostol Revenue Market Share by Application (2017-2028)
5.3 Global Misoprostol Price by Application
5.3.1 Global Misoprostol Price by Application (2017-2022)
5.3.2 Global Misoprostol Price Forecast by Application (2023-2028)
6 North America
6.1 North America Misoprostol Market Size by Type
6.1.1 North America Misoprostol Sales by Type (2017-2028)
6.1.2 North America Misoprostol Revenue by Type (2017-2028)
6.2 North America Misoprostol Market Size by Application
6.2.1 North America Misoprostol Sales by Application (2017-2028)
6.2.2 North America Misoprostol Revenue by Application (2017-2028)
6.3 North America Misoprostol Market Size by Country
6.3.1 North America Misoprostol Sales by Country (2017-2028)
6.3.2 North America Misoprostol Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Misoprostol Market Size by Type
7.1.1 Europe Misoprostol Sales by Type (2017-2028)
7.1.2 Europe Misoprostol Revenue by Type (2017-2028)
7.2 Europe Misoprostol Market Size by Application
7.2.1 Europe Misoprostol Sales by Application (2017-2028)
7.2.2 Europe Misoprostol Revenue by Application (2017-2028)
7.3 Europe Misoprostol Market Size by Country
7.3.1 Europe Misoprostol Sales by Country (2017-2028)
7.3.2 Europe Misoprostol Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Misoprostol Market Size by Type
8.1.1 Asia Pacific Misoprostol Sales by Type (2017-2028)
8.1.2 Asia Pacific Misoprostol Revenue by Type (2017-2028)
8.2 Asia Pacific Misoprostol Market Size by Application
8.2.1 Asia Pacific Misoprostol Sales by Application (2017-2028)
8.2.2 Asia Pacific Misoprostol Revenue by Application (2017-2028)
8.3 Asia Pacific Misoprostol Market Size by Region
8.3.1 Asia Pacific Misoprostol Sales by Region (2017-2028)
8.3.2 Asia Pacific Misoprostol Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Misoprostol Market Size by Type
9.1.1 Latin America Misoprostol Sales by Type (2017-2028)
9.1.2 Latin America Misoprostol Revenue by Type (2017-2028)
9.2 Latin America Misoprostol Market Size by Application
9.2.1 Latin America Misoprostol Sales by Application (2017-2028)
9.2.2 Latin America Misoprostol Revenue by Application (2017-2028)
9.3 Latin America Misoprostol Market Size by Country
9.3.1 Latin America Misoprostol Sales by Country (2017-2028)
9.3.2 Latin America Misoprostol Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Misoprostol Market Size by Type
10.1.1 Middle East and Africa Misoprostol Sales by Type (2017-2028)
10.1.2 Middle East and Africa Misoprostol Revenue by Type (2017-2028)
10.2 Middle East and Africa Misoprostol Market Size by Application
10.2.1 Middle East and Africa Misoprostol Sales by Application (2017-2028)
10.2.2 Middle East and Africa Misoprostol Revenue by Application (2017-2028)
10.3 Middle East and Africa Misoprostol Market Size by Country
10.3.1 Middle East and Africa Misoprostol Sales by Country (2017-2028)
10.3.2 Middle East and Africa Misoprostol Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Corporation Information
11.1.2 Cardinal Health Overview
11.1.3 Cardinal Health Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cardinal Health Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cardinal Health Recent Developments
11.2 PD-Rx Pharmaceutical
11.2.1 PD-Rx Pharmaceutical Corporation Information
11.2.2 PD-Rx Pharmaceutical Overview
11.2.3 PD-Rx Pharmaceutical Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 PD-Rx Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 PD-Rx Pharmaceutical Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Aidarex Pharmaceuticals
11.4.1 Aidarex Pharmaceuticals Corporation Information
11.4.2 Aidarex Pharmaceuticals Overview
11.4.3 Aidarex Pharmaceuticals Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Aidarex Pharmaceuticals Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aidarex Pharmaceuticals Recent Developments
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Corporation Information
11.5.2 Cadila Healthcare Overview
11.5.3 Cadila Healthcare Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cadila Healthcare Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cadila Healthcare Recent Developments
11.6 Monsanto/Searle
11.6.1 Monsanto/Searle Corporation Information
11.6.2 Monsanto/Searle Overview
11.6.3 Monsanto/Searle Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Monsanto/Searle Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Monsanto/Searle Recent Developments
11.7 Shanghai Xinhualian Pharmaceutical
11.7.1 Shanghai Xinhualian Pharmaceutical Corporation Information
11.7.2 Shanghai Xinhualian Pharmaceutical Overview
11.7.3 Shanghai Xinhualian Pharmaceutical Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shanghai Xinhualian Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Xinhualian Pharmaceutical Recent Developments
11.8 China Resources Zizhu Pharmaceutical
11.8.1 China Resources Zizhu Pharmaceutical Corporation Information
11.8.2 China Resources Zizhu Pharmaceutical Overview
11.8.3 China Resources Zizhu Pharmaceutical Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 China Resources Zizhu Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 China Resources Zizhu Pharmaceutical Recent Developments
11.9 Zhejiang Xianju Pharmaceutical
11.9.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.9.2 Zhejiang Xianju Pharmaceutical Overview
11.9.3 Zhejiang Xianju Pharmaceutical Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zhejiang Xianju Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
11.10 Hubei Gedian Renfu Pharmaceutical
11.10.1 Hubei Gedian Renfu Pharmaceutical Corporation Information
11.10.2 Hubei Gedian Renfu Pharmaceutical Overview
11.10.3 Hubei Gedian Renfu Pharmaceutical Misoprostol Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hubei Gedian Renfu Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hubei Gedian Renfu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Misoprostol Industry Chain Analysis
12.2 Misoprostol Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Misoprostol Production Mode & Process
12.4 Misoprostol Sales and Marketing
12.4.1 Misoprostol Sales Channels
12.4.2 Misoprostol Distributors
12.5 Misoprostol Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Misoprostol Industry Trends
13.2 Misoprostol Market Drivers
13.3 Misoprostol Market Challenges
13.4 Misoprostol Market Restraints
14 Key Findings in The Global Misoprostol Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Misoprostol Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 200 ug Tablets
    Table 3. Major Manufacturers of 100 ug Tablets
    Table 4. Global Misoprostol Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Misoprostol Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Misoprostol Sales by Region (2017-2022) & (M Pcs)
    Table 7. Global Misoprostol Sales Market Share by Region (2017-2022)
    Table 8. Global Misoprostol Sales by Region (2023-2028) & (M Pcs)
    Table 9. Global Misoprostol Sales Market Share by Region (2023-2028)
    Table 10. Global Misoprostol Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Misoprostol Revenue Market Share by Region (2017-2022)
    Table 12. Global Misoprostol Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Misoprostol Revenue Market Share by Region (2023-2028)
    Table 14. Global Misoprostol Sales by Manufacturers (2017-2022) & (M Pcs)
    Table 15. Global Misoprostol Sales Share by Manufacturers (2017-2022)
    Table 16. Global Misoprostol Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Misoprostol Revenue Share by Manufacturers (2017-2022)
    Table 18. Misoprostol Price by Manufacturers (2017-2022) &(US$/Pcs)
    Table 19. Global Misoprostol Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Misoprostol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Misoprostol as of 2021)
    Table 21. Misoprostol Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Misoprostol Product Offered
    Table 23. Date of Manufacturers Enter into Misoprostol Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 26. Global Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 27. Global Misoprostol Sales Share by Type (2017-2022)
    Table 28. Global Misoprostol Sales Share by Type (2023-2028)
    Table 29. Global Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Misoprostol Revenue Share by Type (2017-2022)
    Table 32. Global Misoprostol Revenue Share by Type (2023-2028)
    Table 33. Misoprostol Price by Type (2017-2022) & (US$/Pcs)
    Table 34. Global Misoprostol Price Forecast by Type (2023-2028) & (US$/Pcs)
    Table 35. Global Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 36. Global Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 37. Global Misoprostol Sales Share by Application (2017-2022)
    Table 38. Global Misoprostol Sales Share by Application (2023-2028)
    Table 39. Global Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Misoprostol Revenue Share by Application (2017-2022)
    Table 42. Global Misoprostol Revenue Share by Application (2023-2028)
    Table 43. Misoprostol Price by Application (2017-2022) & (US$/Pcs)
    Table 44. Global Misoprostol Price Forecast by Application (2023-2028) & (US$/Pcs)
    Table 45. North America Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 46. North America Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 47. North America Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 50. North America Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 51. North America Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Misoprostol Sales by Country (2017-2022) & (M Pcs)
    Table 54. North America Misoprostol Sales by Country (2023-2028) & (M Pcs)
    Table 55. North America Misoprostol Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Misoprostol Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 58. Europe Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 59. Europe Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 62. Europe Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 63. Europe Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Misoprostol Sales by Country (2017-2022) & (M Pcs)
    Table 66. Europe Misoprostol Sales by Country (2023-2028) & (M Pcs)
    Table 67. Europe Misoprostol Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Misoprostol Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 70. Asia Pacific Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 71. Asia Pacific Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 74. Asia Pacific Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 75. Asia Pacific Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Misoprostol Sales by Region (2017-2022) & (M Pcs)
    Table 78. Asia Pacific Misoprostol Sales by Region (2023-2028) & (M Pcs)
    Table 79. Asia Pacific Misoprostol Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Misoprostol Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 82. Latin America Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 83. Latin America Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 86. Latin America Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 87. Latin America Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Misoprostol Sales by Country (2017-2022) & (M Pcs)
    Table 90. Latin America Misoprostol Sales by Country (2023-2028) & (M Pcs)
    Table 91. Latin America Misoprostol Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Misoprostol Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Misoprostol Sales by Type (2017-2022) & (M Pcs)
    Table 94. Middle East and Africa Misoprostol Sales by Type (2023-2028) & (M Pcs)
    Table 95. Middle East and Africa Misoprostol Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Misoprostol Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Misoprostol Sales by Application (2017-2022) & (M Pcs)
    Table 98. Middle East and Africa Misoprostol Sales by Application (2023-2028) & (M Pcs)
    Table 99. Middle East and Africa Misoprostol Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Misoprostol Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Misoprostol Sales by Country (2017-2022) & (M Pcs)
    Table 102. Middle East and Africa Misoprostol Sales by Country (2023-2028) & (M Pcs)
    Table 103. Middle East and Africa Misoprostol Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Misoprostol Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Cardinal Health Corporation Information
    Table 106. Cardinal Health Description and Major Businesses
    Table 107. Cardinal Health Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 108. Cardinal Health Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Cardinal Health Recent Developments
    Table 110. PD-Rx Pharmaceutical Corporation Information
    Table 111. PD-Rx Pharmaceutical Description and Major Businesses
    Table 112. PD-Rx Pharmaceutical Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 113. PD-Rx Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. PD-Rx Pharmaceutical Recent Developments
    Table 115. Pfizer Corporation Information
    Table 116. Pfizer Description and Major Businesses
    Table 117. Pfizer Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 118. Pfizer Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Pfizer Recent Developments
    Table 120. Aidarex Pharmaceuticals Corporation Information
    Table 121. Aidarex Pharmaceuticals Description and Major Businesses
    Table 122. Aidarex Pharmaceuticals Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 123. Aidarex Pharmaceuticals Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Aidarex Pharmaceuticals Recent Developments
    Table 125. Cadila Healthcare Corporation Information
    Table 126. Cadila Healthcare Description and Major Businesses
    Table 127. Cadila Healthcare Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 128. Cadila Healthcare Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Cadila Healthcare Recent Developments
    Table 130. Monsanto/Searle Corporation Information
    Table 131. Monsanto/Searle Description and Major Businesses
    Table 132. Monsanto/Searle Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 133. Monsanto/Searle Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Monsanto/Searle Recent Developments
    Table 135. Shanghai Xinhualian Pharmaceutical Corporation Information
    Table 136. Shanghai Xinhualian Pharmaceutical Description and Major Businesses
    Table 137. Shanghai Xinhualian Pharmaceutical Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 138. Shanghai Xinhualian Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Shanghai Xinhualian Pharmaceutical Recent Developments
    Table 140. China Resources Zizhu Pharmaceutical Corporation Information
    Table 141. China Resources Zizhu Pharmaceutical Description and Major Businesses
    Table 142. China Resources Zizhu Pharmaceutical Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 143. China Resources Zizhu Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. China Resources Zizhu Pharmaceutical Recent Developments
    Table 145. Zhejiang Xianju Pharmaceutical Corporation Information
    Table 146. Zhejiang Xianju Pharmaceutical Description and Major Businesses
    Table 147. Zhejiang Xianju Pharmaceutical Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 148. Zhejiang Xianju Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Zhejiang Xianju Pharmaceutical Recent Developments
    Table 150. Hubei Gedian Renfu Pharmaceutical Corporation Information
    Table 151. Hubei Gedian Renfu Pharmaceutical Description and Major Businesses
    Table 152. Hubei Gedian Renfu Pharmaceutical Misoprostol Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 153. Hubei Gedian Renfu Pharmaceutical Misoprostol Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Hubei Gedian Renfu Pharmaceutical Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Misoprostol Distributors List
    Table 158. Misoprostol Customers List
    Table 159. Misoprostol Market Trends
    Table 160. Misoprostol Market Drivers
    Table 161. Misoprostol Market Challenges
    Table 162. Misoprostol Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Misoprostol Product Picture
    Figure 3. Global Misoprostol Market Share by Type in 2021 & 2028
    Figure 3. 200 ug Tablets Product Picture
    Figure 4. 100 ug Tablets Product Picture
    Figure 5. Global Misoprostol Market Share by Application in 2021 & 2028
    Figure 6. Gastric Ulcer
    Figure 7. Duodenal Ulcer
    Figure 8. Peptic Ulcer
    Figure 9. Anti-Early Pregnancy
    Figure 10. Other
    Figure 11. Misoprostol Report Years Considered
    Figure 12. Global Misoprostol Sales 2017-2028 (M Pcs)
    Figure 13. Global Misoprostol Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Misoprostol Revenue 2017-2028 (US$ Million)
    Figure 15. Global Misoprostol Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Misoprostol Sales Market Share by Region (2017-2022)
    Figure 17. Global Misoprostol Sales Market Share by Region (2023-2028)
    Figure 18. North America Misoprostol Sales YoY (2017-2028) & (M Pcs)
    Figure 19. North America Misoprostol Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Misoprostol Sales YoY (2017-2028) & (M Pcs)
    Figure 21. Europe Misoprostol Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Misoprostol Sales YoY (2017-2028) & (M Pcs)
    Figure 23. Asia-Pacific Misoprostol Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Misoprostol Sales YoY (2017-2028) & (M Pcs)
    Figure 25. Latin America Misoprostol Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Misoprostol Sales YoY (2017-2028) & (M Pcs)
    Figure 27. Middle East & Africa Misoprostol Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Misoprostol Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Misoprostol in the World: Market Share by Misoprostol Revenue in 2021
    Figure 30. Global Misoprostol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Misoprostol Sales Market Share by Type (2017-2028)
    Figure 32. Global Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 33. Global Misoprostol Sales Market Share by Application (2017-2028)
    Figure 34. Global Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 35. North America Misoprostol Sales Market Share by Type (2017-2028)
    Figure 36. North America Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 37. North America Misoprostol Sales Market Share by Application (2017-2028)
    Figure 38. North America Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 39. North America Misoprostol Sales Share by Country (2017-2028)
    Figure 40. North America Misoprostol Revenue Share by Country (2017-2028)
    Figure 41. U.S. Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Misoprostol Sales Market Share by Type (2017-2028)
    Figure 44. Europe Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Misoprostol Sales Market Share by Application (2017-2028)
    Figure 46. Europe Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Misoprostol Sales Share by Country (2017-2028)
    Figure 48. Europe Misoprostol Revenue Share by Country (2017-2028)
    Figure 49. Germany Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 50. France Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Misoprostol Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Misoprostol Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Misoprostol Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Misoprostol Revenue Share by Region (2017-2028)
    Figure 60. China Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 63. India Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Misoprostol Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Misoprostol Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Misoprostol Sales Share by Country (2017-2028)
    Figure 75. Latin America Misoprostol Revenue Share by Country (2017-2028)
    Figure 76. Mexico Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Misoprostol Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Misoprostol Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Misoprostol Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Misoprostol Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Misoprostol Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Misoprostol Revenue Share by Country (2017-2028)
    Figure 85. Turkey Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Misoprostol Revenue (2017-2028) & (US$ Million)
    Figure 88. Misoprostol Value Chain
    Figure 89. Misoprostol Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States In Vitro Diagnostics Systems Market Report Forecast 2022 2028
Global and United States In Vitro Diagnostics Systems Market Report & Forecast 2022-2028

In vitro diagnostics are diagnostic tests that that can detect diseases conditions or infections.Market Analysis and Insights Global and United States In Vitro Diagnostics Systems MarketThis report focuses on global and United States In Vitro Diagnostics Systems market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global In Vitro Diagnostics Systems market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-12G10564
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Uterine Cancer Therapies and Diagnostic Market Report Forecast 2022 2028
Global and United States Uterine Cancer Therapies and Diagnostic Market Report & Forecast 2022-2028

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus.Market Analysis and Insights Global and United States Uterine Cancer Therapies and Diagnostic MarketThis report focuses on global and United States Uterine Cancer Therapies and Diagnostic market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Uterine Cancer Therapies and Diagnostic market size is estimated to be worth US 21650 million in 2022 and is forecast to a readjusted size of US 28120 million by 2028 with a CAGR of 4.5 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-1I10683
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Prenatal Testing and Newborn Screening Market Report Forecast 2022 2028
Global and United States Prenatal Testing and Newborn Screening Market Report & Forecast 2022-2028

Newborn screening is performed after the baby is born.Market Analysis and Insights Global and United States Prenatal Testing and Newborn Screening MarketThis report focuses on global and United States Prenatal Testing and Newborn Screening market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Prenatal Testing and Newborn Screening market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24T10249
Tue Jun 07 00:00:00 UTC 2022

Add to Cart